In today’s workplace, insurance and retirement benefits are expected. Health insurance, dental and vision plans are commonplace as well. But at OMRF, employees and their families can take advantage of a unique employee benefit—a breast cancer risk assessment test. On Friday, 80 women—OMRF employees and spouses—will take the OncoVue breast cancer risk assessment test. This […]
intergenetics
Oklahoma-based cancer test helps stop a killer
It took 14 years for Oklahoma City biotechnology company InterGenetics to research and develop its breast cancer risk assessment test, OncoVue. But less than a year after becoming commercially available, the test has already begun paying dividends to patients. A California oncologist reports that that the test, which has its origins in research conducted at […]
